Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Ultragenyx Pharmaceutical

    World Rank (Aug-2026)
    5,466
    Market Cap (Aug-2026)
    2.612 Billion USD
    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    673 Million USD
    Annual Operating Income in USD
    -535 Million USD
    Annual Net Income in USD
    -575 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

    Company Website
    ULTRAGENYX PHARMACEUTICAL INC

  2. SELLAS Life Sciences Group

    World Rank (Aug-2026)
    5,497
    Market Cap (Aug-2026)
    2.581 Billion USD
    World Rank (Jan-05-2024)
    27,339
    Market Cap (Jan-05-2024)
    0.029 Billion USD
    World Rank (Jul-30-2023)
    25,548
    Market Cap (Jul-30-2023)
    0.047 Billion USD
    World Rank (Dec-25-2022)
    25,573
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    23,258
    Market Cap (Jan-07-2022)
    0.09 Billion USD
    Annual Operating Income in USD
    -28 Million USD
    Annual Net Income in USD
    -27 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SELLAS LIFE SCIENCES GROUP

  3. Nektar Therapeutics

    World Rank (Aug-2026)
    5,639
    Market Cap (Aug-2026)
    2.467 Billion USD
    World Rank (Jan-05-2024)
    21,027
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    21,502
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    13,797
    Market Cap (Dec-25-2022)
    0.404 Billion USD
    World Rank (Jan-07-2022)
    5,673
    Market Cap (Jan-07-2022)
    2.34 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Operating Income in USD
    -140 Million USD
    Annual Net Income in USD
    -164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Nektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.
    Company Website
    NEKTAR THERAPEUTICS
    Wikipedia
    Wikipedia

  4. Pharvaris N.V.

    World Rank (Aug-2026)
    5,661
    Market Cap (Aug-2026)
    2.448 Billion USD
    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Netherlands
    Yahoo @ Nasdaq
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
    Company Website
    PHARVARIS N.V.

  5. Prestige Consumer Healthcare

    World Rank (Aug-2026)
    5,675
    Market Cap (Aug-2026)
    2.434 Billion USD
    World Rank (Jan-05-2024)
    4,362
    Market Cap (Jan-05-2024)
    3.012 Billion USD
    World Rank (Jul-30-2023)
    4,138
    Market Cap (Jul-30-2023)
    3.219 Billion USD
    World Rank (Dec-25-2022)
    4,012
    Market Cap (Dec-25-2022)
    3.072 Billion USD
    World Rank (Jan-07-2022)
    4,829
    Market Cap (Jan-07-2022)
    3.02 Billion USD
    Annual Revenue in USD
    1,089 Million USD
    Annual Operating Income in USD
    309 Million USD
    Annual Net Income in USD
    190 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    Prestige Consumer Healthcare Manufactures and Distributes Quality in the over-the-counter Health Care and Household Cleaning Products to Retail Stores company. The company brands are digestive care, eye, ear, nose and throat, oral care, pain relief, pediatric care, skin care, sleep aids and women's health. The headquarters is in USA.

    Company Website
    PRESTIGE CONSUMER HEALTHCARE

  6. Amylyx Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,709
    Market Cap (Aug-2026)
    2.410 Billion USD
    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -153 Million USD
    Annual Net Income in USD
    -145 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
    Company Website
    AMYLYX PHARMACEUTICALS, INC.

  7. Urogen Pharma

    World Rank (Aug-2026)
    5,781
    Market Cap (Aug-2026)
    2.357 Billion USD
    World Rank (Jan-05-2024)
    13,467
    Market Cap (Jan-05-2024)
    0.435 Billion USD
    World Rank (Jul-30-2023)
    12,378
    Market Cap (Jul-30-2023)
    0.530 Billion USD
    World Rank (Dec-25-2022)
    18,356
    Market Cap (Dec-25-2022)
    0.188 Billion USD
    World Rank (Jan-07-2022)
    18,931
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Annual Revenue in USD
    110 Million USD
    Annual Operating Income in USD
    -125 Million USD
    Annual Net Income in USD
    -153 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    UroGen Pharma is a Biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. The company annual revenue is 3.5 million USD and 156 employees as on 2020. The headquarters is in USA.
    Company Website
    UROGEN PHARMA

  8. Vera Therapeutics Inc.

    World Rank (Aug-2026)
    5,905
    Market Cap (Aug-2026)
    2.279 Billion USD
    World Rank (Jan-05-2024)
    10,674
    Market Cap (Jan-05-2024)
    0.689 Billion USD
    World Rank (Jul-30-2023)
    10,207
    Market Cap (Jul-30-2023)
    0.761 Billion USD
    World Rank (Dec-25-2022)
    11,799
    Market Cap (Dec-25-2022)
    0.550 Billion USD
    World Rank (Jan-07-2022)
    14,196
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Operating Income in USD
    -315 Million USD
    Annual Net Income in USD
    -300 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    VERA THERAPEUTICS, INC.

  9. Mineralys Therapeutics Inc.

    World Rank (Aug-2026)
    5,921
    Market Cap (Aug-2026)
    2.267 Billion USD
    World Rank (Jan-05-2024)
    14,697
    Market Cap (Jan-05-2024)
    0.355 Billion USD
    World Rank (Jul-30-2023)
    14,411
    Market Cap (Jul-30-2023)
    0.382 Billion USD
    Annual Operating Income in USD
    -171 Million USD
    Annual Net Income in USD
    -155 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    Mineralys Therapeutics Inc.

  10. Harmony Biosciences Holdings Inc.

    World Rank (Aug-2026)
    5,989
    Market Cap (Aug-2026)
    2.220 Billion USD
    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    868 Million USD
    Annual Operating Income in USD
    208 Million USD
    Annual Net Income in USD
    159 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

    Company Website
    HARMONY BIOSCIENCES HOLDINGS, INC.

Share